Risk of cardiovascular disease following gonadotropin-releasing hormone agonists vs antagonists in prostate cancer: Real-world evidence from five databases

May-21

Cardiovascular Men's Health Oncology Pharmacoepidemiology

AUTHORS : Dr Gincy George, King’s College London, Translational Oncology and Urology Research, London, SE1 9RT, UK – Email: gincy.e.george@kcl.ac.uk – Profile: https://www.kcl.ac.uk/people/gincy-george

JOURNAL : International Journal of Cancer

REFERENCE: 148(9):2203-2211

DOI : 10.1002/ijc.33397

Read more

More publications

Jan-25

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: a population-based cohort study

Pharmacoepidemiology

Read more

Jan-25

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes

Pharmacoepidemiology

Read more

Jan-25

Association Between Type 2 Diabetes Onset Age and Risk of Cardiovascular Disease and Mortality: Two Cohort Studies from United Kingdom and Hong Kong

Cardiovascular

Read more